NCT03425643 · Interventional trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Overall registry status Completed
Phase 3
Conditions Non-small Cell Lung Cancer
Delaware Valley sites
- Cancer Treatment Centers of America-Eastern Regional Medical Center ( Site 0053) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory